Novacyt (NCYT) Competitors

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

GBX 70

+5.60 (+8.70%)

(As of 04/19/2024 ET)

Stock Analysis Chart Competitors Headlines Insider Trades

NCYT vs. IUG, IHC, BELL, EKF, CREO, AGL, RENX, AREC, TRX, and REDX

Should you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include Intelligent Ultrasound Group (IUG), Inspiration Healthcare Group (IHC), Belluscura (BELL), EKF Diagnostics (EKF), Creo Medical Group (CREO), ANGLE (AGL), Renalytix (RENX), Arecor Therapeutics (AREC), Tissue Regenix Group (TRX), and Redx Pharma (REDX). These companies are all part of the "medical" sector.

Novacyt vs.

Intelligent Ultrasound Group (LON:IUG) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, community ranking, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intelligent Ultrasound Group
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Novacyt
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Intelligent Ultrasound Group has a beta of 0.08, meaning that its stock price is 92% less volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.73, meaning that its stock price is 273% less volatile than the S&P 500.
: Novacyt has a net margin of 0.00% compared to Novacyt's net margin of -31.08%. Intelligent Ultrasound Group's return on equity of -21.08% beat Novacyt's return on equity.
Company Net Margins Return on Equity Return on Assets
Intelligent Ultrasound Group -31.08% -31.77% -17.61%
Novacyt N/A -21.08% -5.88%
: Novacyt received 36 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.
Company Underperform Outperform
Intelligent Ultrasound Group N/A N/A
Novacyt Outperform Votes
36
58.06%
Underperform Votes
26
41.94%
: Intelligent Ultrasound Group has higher revenue and earnings than Novacyt. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Intelligent Ultrasound Group £10.26M 2.71 -£3.19M -£0.01 -850.00
Novacyt £7.87M 6.28 -£25.30M -£0.36 -194.44
: 79.7% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 0.1% of Novacyt shares are held by institutional investors. 11.9% of Intelligent Ultrasound Group shares are held by insiders. Comparatively, 3.4% of Novacyt shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: In the previous week, Novacyt had 2 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 2 mentions for Novacyt and 0 mentions for Intelligent Ultrasound Group. Novacyt's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score.
Company Overall Sentiment
Intelligent Ultrasound Group Neutral
Novacyt Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Ultrasound Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Novacyt	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Ultrasound Group	-31.08%	-31.77%	-17.61%
Novacyt	N/A	-21.08%	-5.88%

Company	Underperform	Outperform
Intelligent Ultrasound Group	N/A	N/A
Novacyt	Outperform Votes 36 58.06%	Underperform Votes 26 41.94%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Ultrasound Group	£10.26M	2.71	-£3.19M	-£0.01	-850.00
Novacyt	£7.87M	6.28	-£25.30M	-£0.36	-194.44

Company	Overall Sentiment
Intelligent Ultrasound Group	Neutral
Novacyt	Neutral

Summary

Novacyt beats Intelligent Ultrasound Group on 7 of the 13 factors compared between the two stocks.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Get Novacyt News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NCYT vs. The Competition

Export to Excel

Metric	Novacyt	Medical Devices Industry	Medical Sector	LON Exchange
Market Cap	£49.44M	£2.29B	£4.79B	£1.43B
Dividend Yield	N/A	2.50%	2.93%	12.21%
P/E Ratio	-194.44	209.84	235.97	1,801.81
Price / Sales	6.28	222.38	2,475.50	330,691.48
Price / Cash	0.58	16.62	47.07	34.02
Price / Book	0.46	4.39	4.55	2.56
Net Income	-£25.30M	£65.40M	£103.85M	£182.99M
7 Day Performance	39.25%	-0.69%	-4.50%	-0.58%
1 Month Performance	53.42%	-3.60%	-6.07%	12.55%
1 Year Performance	28.56%	46.63%	6.72%	16.85%

Novacyt Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IUG Intelligent Ultrasound Group	0 of 5 stars	GBX 9.40 -1.1%	N/A	-14.3%	£30.73M	£10.26M	-940.00	65
IHC Inspiration Healthcare Group	0 of 5 stars	GBX 28.90 +0.3%	N/A	-43.1%	£19.72M	£41.08M	-2,890.00	210
BELL Belluscura	0 of 5 stars	GBX 8.90 -1.1%	N/A	-82.0%	£14.63M	£1.20M	-148.33	24
EKF EKF Diagnostics	0 of 5 stars	GBX 27.90 +0.4%	N/A	-6.8%	£126.59M	£52.61M	2,790.00	356	News Coverage Positive News
CREO Creo Medical Group	0 of 5 stars	GBX 37.82 -3.0%	N/A	+29.6%	£136.70M	£29.27M	-343.78	279	News Coverage
AGL ANGLE	0.7065 of 5 stars	GBX 13.88 -11.9%	GBX 120 +764.6%	-30.9%	£36.17M	£1.82M	-154.22	173
RENX Renalytix	0 of 5 stars	GBX 29.61 +2.1%	N/A	-68.8%	£35.51M	£2.41M	-82.25	102
AREC Arecor Therapeutics	0 of 5 stars	GBX 140 -1.8%	N/A	-52.4%	£42.88M	£3.38M	-451.61	51	News Coverage
TRX Tissue Regenix Group	0 of 5 stars	GBX 61.50 flat	N/A	+10,323.7%	£43.40M	£29.49M	-3,075.00	82	Positive News
REDX Redx Pharma	0 of 5 stars	GBX 6.70 +16.5%	N/A	-61.4%	£26.06M	£4.20M	-67.00	101	Insider Buying High Trading Volume

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (LON:NCYT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Novacyt (NCYT) Competitors

NCYT vs. IUG, IHC, BELL, EKF, CREO, AGL, RENX, AREC, TRX, and REDX

Novacyt vs.

Summary

Media Sentiment Over Time

NCYT vs. The Competition

Novacyt Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info